CHUGAI PHARMACEUTICAL CO., LTD., July-September (3Q) Net Income Increases by 41%, Current Fiscal Year Dividend Revised from 82 yen to Undecided

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Oct 25, 2024 5:00 pm JST Earnings

4519 CHUGAI PHARMACEUTICAL CO., LTD. 【IFRS】

Earnings Report

CHUGAI PHARMACEUTICAL CO., LTD. <4519> [TSE-P] announced its financial results (based on IFRS) after the market closed on October 25th (17:00). The consolidated net income for the cumulative third quarter of the fiscal year ending December 2024 (January to September) increased by 26.2% from the same period last year, reaching 295 billion yen.

At the same time, the plan for a annual dividend of 82 yen has been changed to undecided.

In the most recent three-month period, from July to September (3Q), the consolidated net income increased by 41.2% from the same period last year, reaching 109 billion yen. The operating profit margin rose from 41.4% in the same period last year to 50.8%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jan - Sep, 2022	821,231	383,835	381,950	271,950	165.4	71.9	Oct 24, 2022	IFRS
Jan - Sep, 2023	837,555	317,598	321,131	234,266	142.4	72.4	Oct 24, 2023	IFRS
Jan - Sep, 2024	868,538	418,602	417,527	295,758	179.8	ー	Oct 25, 2024	IFRS
YoY	+3.7%	+31.8%	+30.0%	+26.2%	+26.2%

Guidance Update

Second Half Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul - Dec, 2024 Prev	517,140	ー	ー	ー	－	41	Jul 25, 2024	IFRS
Jul - Dec, 2024 New	597,140	ー	ー	ー	－	－	Oct 25, 2024	IFRS
Revision Rate	+15.5%	－	－	－	－

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2024 Prev	1,070,000	ー	ー	ー	－	82	Feb 1, 2024	IFRS
Dec, 2024 New	1,150,000	ー	ー	ー	－	－	Oct 25, 2024	IFRS
Revision Rate	+7.5%	－	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul - Dec, 2023	531,710	228,264	230,165	168,779	102.6	40	Feb 1, 2024	IFRS
Jul - Dec, 2024 Guidance	597,140	ー	ー	ー	－	－	Oct 25, 2024	IFRS
YoY	+12.3%	－	－	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2022	1,259,726	533,309	531,166	374,429	227.6	78	Feb 2, 2023	IFRS
Dec, 2023	1,111,367	439,174	443,821	325,472	197.8	80	Feb 1, 2024	IFRS
Dec, 2024 Guidance	1,150,000	ー	ー	ー	－	－	Oct 25, 2024	IFRS
YoY	+3.5%	－	－	－	－

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jul - Sep, 2023	257,898	106,688	107,475	77,573	47.2	41.4	Oct 24, 2023	IFRS
Oct - Dec, 2023	273,812	121,576	122,690	91,206	55.4	44.4	Feb 1, 2024	IFRS
Jan - Mar, 2024	236,949	99,874	99,889	74,401	45.2	42.1	Apr 24, 2024	IFRS
Apr - Jun, 2024	315,911	158,321	158,801	111,861	68.0	50.1	Jul 25, 2024	IFRS
Jul - Sep, 2024	315,678	160,407	158,837	109,496	66.6	50.8	Oct 25, 2024	IFRS
YoY	+22.4%	+50.4%	+47.8%	+41.2%	+41.1%